Immunoglobulin E (IgE) Allergy Blood Tests - Medical Devices Pipeline Assessment, 2018

Immunoglobulin E (IgE) Allergy Blood Tests - Medical Devices Pipeline Assessment, 2018


  • Products Id :- GDME0654EPD
  • |
  • Pages: 67
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Immunoglobulin E (IgE) Allergy Blood Tests-Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, Immunoglobulin E (IgE) Allergy Blood Tests-Medical Devices Pipeline Assessment, 2018" provides an overview of Immunoglobulin E (IgE) Allergy Blood Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Immunoglobulin E (IgE) Allergy Blood Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Immunoglobulin E (IgE) Allergy Blood Tests under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Immunoglobulin E (IgE) Allergy Blood Tests and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry.

Reasons to buy

The report enables you to-

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Immunoglobulin E (IgE) Allergy Blood Tests under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 5

2 Introduction 6

2.1 Immunoglobulin E (IgE) Allergy Blood Tests Overview 6

3 Products under Development 7

3.1 Immunoglobulin E (IgE) Allergy Blood Tests-Pipeline Products by Stage of Development 7

3.2 Immunoglobulin E (IgE) Allergy Blood Tests-Pipeline Products by Segment 8

3.3 Immunoglobulin E (IgE) Allergy Blood Tests-Pipeline Products by Territory 9

3.4 Immunoglobulin E (IgE) Allergy Blood Tests-Pipeline Products by Regulatory Path 10

3.5 Immunoglobulin E (IgE) Allergy Blood Tests-Pipeline Products by Estimated Approval Date 11

4 Immunoglobulin E (IgE) Allergy Blood Tests-Pipeline Products under Development by Companies 12

4.1 Immunoglobulin E (IgE) Allergy Blood Tests Companies-Pipeline Products by Stage of Development 12

4.2 Immunoglobulin E (IgE) Allergy Blood Tests-Pipeline Products by Stage of Development 13

5 Immunoglobulin E (IgE) Allergy Blood Tests Companies and Product Overview 14

5.1 Abionic SA Company Overview 14

5.2 Amerimmune Company Overview 16

5.3 AXO Science SAS Company Overview 18

5.4 Biovator AB (Inactive) Company Overview 19

5.5 Children's Hospital Boston Company Overview 20

5.6 China Medical Technologies Inc (Inactive) Company Overview 22

5.7 Cytognos, SL Company Overview 23

5.8 EUROIMMUN US LLC Company Overview 24

5.9 Ferrer inCode SL Company Overview 26

5.10 HOB Biotech Group Suzhou Co Ltd Company Overview 27

5.11 Hycor Biomedical Inc Company Overview 28

5.12 Institut fur Produktqualitat GmbH Company Overview 30

5.13 IRCCS San Raffaele Hospital Company Overview 31

5.14 Medical Research Council Company Overview 32

5.15 Stanford University Company Overview 33

5.16 Thermo Fisher Scientific Inc Company Overview 34

5.17 University of Connecticut Health Center Company Overview 35

5.18 University of Nottingham Company Overview 36

5.19 University of Queensland Company Overview 37

5.20 VEGA Ltd Company Overview 38

6 Immunoglobulin E (IgE) Allergy Blood Tests- Recent Developments 39

6.1 Jul 02, 2018: Arrayit Completes Allergy Testing Pilot Program for One of the Nation's Largest Retail Chains 39

6.2 Jun 12, 2018: Change at the top of the Segment Advanced Therapies at Siemens Healthineers 39

6.3 May 10, 2018: Researchers develop a new test to safely and accurately diagnose peanut allergies 40

6.4 May 08, 2018: Omega Diagnostics Group Announced CE-Mark for Allersys 40

6.5 May 03, 2018: Scientists develop a new test to safely and accurately diagnose peanut allergies 40

6.6 May 03, 2018: Siemens Healthineers fully on track to meet the targets 42

6.7 Apr 25, 2018: Thermo Fisher Scientific Reports First Quarter 2018 Results 43

6.8 Apr 10, 2018: Theradiag reports its 2017 annual results and sales for first quarter 2018 44

6.9 Mar 16, 2018: Thermo Fisher Scientific Announces Plans To Build State-Of-The-Art Pharma Services Facility In Rheinfelden 46

6.10 Feb 20, 2018: Theradiag Announces 2017 Annual Sales and Cash Flow at End 2017 47

6.11 Feb 15, 2018: NuVision follows its vision with GBP500,000 investment 48

6.12 Jan 31, 2018: Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2017 Results 48

6.13 Jan 31, 2018: Thermo Fisher Scientific Uses Tax Reform Benefit to Make Additional Investments in Colleagues, Customers and Communities 51

6.14 Jan 30, 2018: Siemens Healthineers Names Deepak Nath Head of Laboratory Diagnostics 51

6.15 Dec 29, 2017: Thermo Fisher Scientific Completes Acquisition of Phenom-World 52

6.16 Dec 21, 2017: Omega Diagnostics Group Receives CE-Mark for Allersys 52

6.17 Dec 19, 2017: THERADIAG provides an update on Prestizia and its partnership with HOB Biotech 52

6.18 Dec 06, 2017: Abionic Announces Appointment of Leading Diagnostics Industry Experts to Board of Directors 53

6.19 Nov 29, 2017: Siemens plans to list Siemens Healthineers on Frankfurt Stock Exchange 53

6.20 Oct 26, 2017: Theradiag: Revenues at the end of September 30, 2017 54

6.21 Oct 25, 2017: Thermo Fisher Scientific Reports Third Quarter 2017 Results 54

6.22 Oct 20, 2017: Abionic Announces FDA Registration for World's Most Rapid Allergy Test and abioSCOPE Diagnostic Testing Platform 57

6.23 Sep 19, 2017: Theradiag: Results and activity for the first half of 2017 Continued improvement in results 58

6.24 Jul 26, 2017: Thermo Fisher Scientific Reports Second Quarter 2017 Results 60

6.25 Jul 25, 2017: Theradiag: Further Strong Sales Growth in the First Half of 2017: +9% 62

6.26 Jul 12, 2017: Premaitha Health: Investment Agreement Extension with Thermo Fisher Scientific 62

7 Appendix 64

7.1 Methodology 64

7.2 About GlobalData 67

7.3 Contact Us 67

7.4 Disclaimer 67

1.2 List of Figures

Figure 1: Immunoglobulin E (IgE) Allergy Blood Tests-Pipeline Products by Stage of Development 7

Figure 2: Immunoglobulin E (IgE) Allergy Blood Tests-Pipeline Products by Segment 8

Figure 3: Immunoglobulin E (IgE) Allergy Blood Tests-Pipeline Products by Territory 9

Figure 4: Immunoglobulin E (IgE) Allergy Blood Tests-Pipeline Products by Regulatory Path 10

Figure 5: Immunoglobulin E (IgE) Allergy Blood Tests-Pipeline Products by Estimated Approval Date 11

1.1 List of Tables

Table 1: Immunoglobulin E (IgE) Allergy Blood Tests-Pipeline Products by Stage of Development 7

Table 2: Immunoglobulin E (IgE) Allergy Blood Tests-Pipeline Products by Segment 8

Table 3: Immunoglobulin E (IgE) Allergy Blood Tests-Pipeline Products by Territory 9

Table 4: Immunoglobulin E (IgE) Allergy Blood Tests-Pipeline Products by Regulatory Path 10

Table 5: Immunoglobulin E (IgE) Allergy Blood Tests-Pipeline Products by Estimated Approval Date 11

Table 6: Immunoglobulin E (IgE) Allergy Blood Tests Companies-Pipeline Products by Stage of Development 12

Table 7: Immunoglobulin E (IgE) Allergy Blood Tests-Pipeline Products by Stage of Development 13

Table 8: Abionic SA Pipeline Products & Ongoing Clinical Trials Overview 14

Table 9: abioKIT-a-6 Tests In 12 Min-Product Status 14

Table 10: abioKIT-a-6 Tests In 12 Min-Product Description 14

Table 11: IVD CAPSULE Aeroallergens-Product Status 15

Table 12: IVD CAPSULE Aeroallergens-Product Description 15

Table 13: Amerimmune Pipeline Products & Ongoing Clinical Trials Overview 16

Table 14: Basophile Panel-Product Status 16

Table 15: Basophile Panel-Product Description 16

Table 16: CD69 and IgE Receptor Expression Assay-Product Status 17

Table 17: CD69 and IgE Receptor Expression Assay-Product Description 17

Table 18: AXO Science SAS Pipeline Products & Ongoing Clinical Trials Overview 18

Table 19: Diagnostic Test-Allergy-Product Status 18

Table 20: Diagnostic Test-Allergy-Product Description 18

Table 21: Biovator AB (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 19

Table 22: Cytokine Profile Assay-Product Status 19

Table 23: Cytokine Profile Assay-Product Description 19

Table 24: Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 20

Table 25: Biomarker Assay-Allergy-Product Status 20

Table 26: Biomarker Assay-Allergy-Product Description 21

Table 27: China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 22

Table 28: Diagnostic Assay-Total IgE-Product Status 22

Table 29: Diagnostic Assay-Total IgE-Product Description 22

Table 30: Cytognos, SL Pipeline Products & Ongoing Clinical Trials Overview 23

Table 31: Diagnosis Flow Cytometry Kit-Type 1 Hypersensitivity-Product Status 23

Table 32: Diagnosis Flow Cytometry Kit-Type 1 Hypersensitivity-Product Description 23

Table 33: EUROIMMUN US LLC Pipeline Products & Ongoing Clinical Trials Overview 24

Table 34: IgE Allergy Test-DP 3134-1601-1 E-Product Status 24

Table 35: IgE Allergy Test-DP 3134-1601-1 E-Product Description 24

Table 36: IgE Allergy Test-DP 3134-1601-2 E-Product Status 25

Table 37: IgE Allergy Test-DP 3134-1601-2 E-Product Description 25

Table 38: Ferrer inCode SL Pipeline Products & Ongoing Clinical Trials Overview 26

Table 39: DAP-Product Status 26

Table 40: DAP-Product Description 26

Table 41: HOB Biotech Group Suzhou Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 27

Table 42: HOB Biotech Diagnostic Assay-Allergy-Product Status 27

Table 43: HOB Biotech Diagnostic Assay-Allergy-Product Description 27

Table 44: Hycor Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 28

Table 45: HYTEC 288 PLUS-Eosinophil Cationic Protein Test-Product Status 28

Table 46: HYTEC 288 PLUS-Eosinophil Cationic Protein Test-Product Description 28

Table 47: HYTEC 288 PLUS-Tryptase Test-Product Status 29

Table 48: HYTEC 288 PLUS-Tryptase Test-Product Description 29

Table 49: Institut fur Produktqualitat GmbH Pipeline Products & Ongoing Clinical Trials Overview 30

Table 50: Diagnostic Test-Allergy-Product Status 30

Table 51: Diagnostic Test-Allergy-Product Description 30

Table 52: IRCCS San Raffaele Hospital Pipeline Products & Ongoing Clinical Trials Overview 31

Table 53: Diagnostic Test-Allergic Asthma-Product Status 31

Table 54: Diagnostic Test-Allergic Asthma-Product Description 31

Table 55: Medical Research Council Pipeline Products & Ongoing Clinical Trials Overview 32

Table 56: Mast Activation Test-Product Status 32

Table 57: Mast Activation Test-Product Description 32

Table 58: Stanford University Pipeline Products & Ongoing Clinical Trials Overview 33

Table 59: Basophil Activation Test-Product Status 33

Table 60: Basophil Activation Test-Product Description 33

Table 61: Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 34

Table 62: Diagnostic Test-Allergy-Product Status 34

Table 63: Diagnostic Test-Allergy-Product Description 34

Table 64: University of Connecticut Health Center Pipeline Products & Ongoing Clinical Trials Overview 35

Table 65: Ultrasensitive Peanut Allergy Test-Product Status 35

Table 66: Ultrasensitive Peanut Allergy Test-Product Description 35

Table 67: University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview 36

Table 68: Allergy Test-Product Status 36

Table 69: Allergy Test-Product Description 36

Table 70: University of Queensland Pipeline Products & Ongoing Clinical Trials Overview 37

Table 71: Diagnostic Assay-Allergy-Product Status 37

Table 72: Diagnostic Assay-Allergy-Product Description 37

Table 73: VEGA Ltd Pipeline Products & Ongoing Clinical Trials Overview 38

Table 74: Microarray Based Allergen Diagnostic Kit-Product Status 38

Table 75: Microarray Based Allergen Diagnostic Kit-Product Description 38

Table 76: Glossary 66

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Abionic SA

Amerimmune

AXO Science SAS

Biovator AB

Children's Hospital Boston

China Medical Technologies Inc

Cytognos, SL

EUROIMMUN US LLC

Ferrer inCode SL

HOB Biotech Group Suzhou Co Ltd

Hycor Biomedical Inc

Institut fur Produktqualitat GmbH

IRCCS San Raffaele Hospital

Medical Research Council

Stanford University

Thermo Fisher Scientific Inc

University of Connecticut Health Center

University of Nottingham

University of Queensland

VEGA Ltd

Abionic SA, abioKIT-a - 6 Tests In 12 Min; Abionic SA, IVD CAPSULE Aeroallergens; Amerimmune, Basophile Panel; Amerimmune, CD69 and IgE Receptor Expression Assay; AXO Science SAS, Diagnostic Test - Allergy; Biovator AB (Inactive), Cytokine Profile Assay; Children's Hospital Boston, Biomarker Assay - Allergy; China Medical Technologies Inc (Inactive), Diagnostic Assay - Total IgE; Cytognos, SL, Diagnosis Flow Cytometry Kit - Type 1 Hypersensitivity; EUROIMMUN US LLC, IgE Allergy Test - DP 3134-1601-1 E; EUROIMMUN US LLC, IgE Allergy Test - DP 3134-1601-2 E; Ferrer inCode SL, DAP; HOB Biotech Group Suzhou Co Ltd, HOB Biotech Diagnostic Assay - Allergy; Hycor Biomedical Inc, HYTEC 288 PLUS - Eosinophil Cationic Protein Test; Hycor Biomedical Inc, HYTEC 288 PLUS - Tryptase Test; Institut fur Produktqualitat GmbH, Diagnostic Test - Allergy; IRCCS San Raffaele Hospital, Diagnostic Test - Allergic Asthma; Medical Research Council, Mast Activation Test; Stanford University, Basophil Activation Test; Thermo Fisher Scientific Inc, Diagnostic Test - Allergy; University of Connecticut Health Center, Ultrasensitive Peanut Allergy Test; University of Nottingham, Allergy Test; University of Queensland, Diagnostic Assay - Allergy; VEGA Ltd, Microarray Based Allergen Diagnostic Kit

select a license
Single User License
USD 2500 INR 172500
Site License
USD 5000 INR 345000
Corporate User License
USD 7500 INR 517500

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com